• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

DrChrono, Genomind Partner on EHR-Integrated Personalized Genetic Tests

by Jasmine Pennic 10/01/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

DrChrono, Genomind Partner on EHR-Integrated Personalized Genetic Tests

EHR provider DrChrono Inc. and Genomind, which offers a unique personalized medicine platform that brings innovation to healthcare around the world, today announce a partnership to meet the growing need from both patients and doctors for personalized genetic tests that integrate with electronic health records.

AS part of the partnership, physician practices using DrChrono’s platform can order test kits for Genomind’s Genecept Assay®, which helps guide mental health treatment and has been used by over 120,000 patients. The partnership also includes Genomind’s Mindful DNA Professional®, a genetic test used by clinicians that helps guide lifestyle, diet and/or nutritional supplement decisions to improve the overall health and wellbeing of patients.

The partnership means participating doctors can access Genecept Assay and Mindful DNA Professional patient test results and use Genomind’s real-time gene-drug-environmental interaction tool, Genomind Drug Interaction Guide (G-DIG)®.  G-DIG allows the clinician to utilize the Genecept Assay results and enter a current medication regiment when considering what medications to prescribe to a patient; it quickly checks for gene-drug and drug-drug interactions.

Clinicians and patients will benefit in important ways from the partnership.  When a physician orders test kits through the DrChrono electronic health record platform, it will capture patient demographics and applicable clinical information.  Doctors also will be able to see test results in the application, and final results are stored in the DrChrono information library for the patient, becoming part of the patient’s medical record.

 

“We are proud that DrChrono, after a thorough review, has chosen Genomind for this important initiative.  DrChrono is a leader in helping doctors focus on what matters most—the patient,” said Dr. David Krause, Chief Medical Officer at Genomind.  “We often hear from patients whose health and quality of life have been dramatically improved by Genomind’s genetic test products, whether in the form of medication optimization through information provided by the Genecept Assay or an improvement in wellness provided by Mindful DNA Professional results. We are excited to help even more patients get better, by partnering with DrChrono and the practices it supports.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: drchrono, Genetic Tests

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |